[1] FIRE A，XU S，MONTGOMERY M K，et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans[J] .Nature，1998，391(6669)： 806-811. [2] CAPLEN N J. Gene Therapy Progress and Prospects. Downregulating gene expression： the impact of RNA interference[J] .Gene Therapy，2004，11(16)：1241-1248. [3] MA P P，XUE S P，HAN D S. Principles and applications of RNA interfering technology[J] .Chin J Histochem Cytochem (中国组织化学与细胞化学杂志)，2003，12(2)： 201-207. [4] SIDDHESH D，DAVID G，DIANE J.DNA-based therapeutics and DNA delivery systems： A comprehensive review[J] .The AAPS J，2005，7(1)： E61-E77. [5] DORSETT Y，TUSCHL T. siRNAs： applications in functional genomics and potential as therapeutics[J] .Nat Rev Drug Discov，2004，3(4)： 318-329. [6] RAY K M，PAUL A. RNA interference： from gene silencing to gene-specific therapeutics[J] .Pharmacology Therapeutics，2005，107(2)： 222-239. [7] RYTHER R C，FLYNT A S，Phillips J A，et al. siRNA therapeutics： big potential from small RNAs[J] .Gene Therapy，2005，12(1)： 5-11. [8] NOVINA C D，SHARP P A.The RNAi revolution[J] .Nature，2004，430(6996)： 161-164. [9] REN X，SONG Y G，CHEN X Q. Progress in research of RNAi[J] . World Clin J Digestol(世界华人消化杂志)，2004，12(3)： 748-750. [10] BARIK S. Development of gene-specific double-stranded RNA drugs[J] .Ann Med，2004，36： 540-551. [11] GONG H，LIU C M，LIU D P，et al. The role of small RNAs in human diseases： potential troublemaker and therapeutic tools[J] .Med Res Rev，2005，25(3)： 361-381. [12] SHLOMAI A，SHAUL Y. RNA interference--small RNAs effectively fight viral hepatitis[J] .Liver Int，2004，24(6)： 526-531. [13] BERKHOUT B. RNA interference as an antiviral approach： targeting HIV-1[J] .Curr Opin Mol Ther，2004，6(2)： 141-145. [14] SUN J. Progress in using RNA interference against HIV infection[J] . Clin Pharm J(中国药学杂志)，2005，40(2)： 84-86. [15] KRONKE J，KITTLER R，BUCHHOLZ F，et al. Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs[J] .J Virol，2004，78(7)： 3436-3446. [16] YUAN J，CHEUNG P K，ZHANG H M，et al. Inhibition of coxsackievirus B3 replication by small interfering RNAs requires perfect sequence match in the central region of the viral positive strand[J] .J Virol，2005，79(4)： 2151-2159. [17] ZHENG B J，GUAN Y，TANG Q，et al. Prophylactic and therapeutic effects of small interfering RNA targeting SARS-coronavirus[J] . Antivir Ther，2004，9(3)： 365-374. [18] MOHAPATRA J K，SANYAL A，HEMADRI D，et al.Evaluation of in vitro inhibitory potential of small interfering RNAs directed against various regions of foot-and-mouth disease virus genome[J] .Biochem Biophys Res Commun，2005，329(3)： 1133-1138. [19] KUMAR R，ADAMS B，OLDENBURG A，et al. Characterisation and expression of a PP1 serine/threonine protein phosphatase (PfPP1) from the malaria parasite，Plasmodium falciparum：demonstration of its essential role using RNA interference[J] .Malar J，2002，1(1)：5. [20] VAYSSIE L，VARGAS M，WEBER C，et al. Double-stranded RNA mediates homology-dependant gene silencing of gamma-tubulin in the human parasite Entamoeba histolytica[J] .Mol Biochem Parasitol，2004，138(1)：21-28. [21] YANG Z，CLOUD A，HUGHES D，et al. Stable inhibition of human thymidylate synthase expression following retroviral introduction of an siRNA gene[J] .Cancer Gene Ther，2006，13(1)： 107-114. [22] WANNENES F，CIAFRE S A，NIOLA F，et al. Vector-based RNA interference against vascular endothelial growth factor-A significantly limits vascularization and growth of prostate cancer in vivo[J] .Cancer Gene Ther，2005，12(12)： 926-934. [23] CHEN Z J，KREN B T，WONG P Y，et al. Sleeping beauty-mediated down-regulation of huntingtin expression by RNA interference[J] . Biochem Biophys Res Commun，2005，329(2)： 646-652. [24] XIA X G，ZHOU H，ZHOU S，et al. An RNAi strategy for treatment of amyotrophic lateral sclerosis caused by mutant Cu，Zn superoxide dismutase[J] .J Neurochem，2005，92(2)： 362-367. [25] MILLER T M，KASPAR B K，KOPS G J，et al. Virus-delivered small RNA silencing sustains strength in amyotrophic lateral sclerosis[J] .Ann Neurol，2005，57(5)： 773-776. [26] ZHANG X Q. The concept，character，and implication of gene therapy[J] .Nature Magazine(自然杂志)，2003，25(3)： 153-156. [27] SOUTSCHEK J，AKINC A，BRAMLAGE B，et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs[J] .Nature，2004，432(7014)： 173-178. [28] JOHN J A. Cholesterol connection in RNAi[J] .Nature，2004，432(7014)： 155-156. [29] CROMBIE C，FRASER A. Treating genetic disease through RNA interference[J] .Lancet，2005，365(9467)： 1288-1290. [30] GUO X H，HAN X X，ZHOU X Z.The gene delivery technology in gene therapy[J] .Letters Biotechnol(生物技术通讯)，2003，14(3)： 235-237. [31] ELMEN J，THONBERG H，LJUNGBERG K，et al. Locked nucleic acid (LNA)mediated improvements in siRNA stability and functionality[J] .Nucleic Acids Res，2005，33(1)：439-447.